Cargando…

Excessive sweating in a male patient caused by milnacipran

Detalles Bibliográficos
Autor principal:	Shinohara, Yutaka
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2009
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755167/ https://www.ncbi.nlm.nih.gov/pubmed/19823644 http://dx.doi.org/10.4103/0019-5545.49465

Ejemplares similares

Use of milnacipran in patients suffering from poststroke depression
por: Arora, Harish, et al.
Publicado: (2009)

Effect of high-dose milnacipran in patients with depression
por: Hayashi, Masatoshi, et al.
Publicado: (2007)

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression
por: Higuchi, Hisashi, et al.
Publicado: (2009)

On Excessive Sweating
por: Foot, Arthur Wynne
Publicado: (1869)

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
por: Yoshimura, Reiji, et al.
Publicado: (2022)

Milnacipran: a unique antidepressant?
por: Kasper, Siegfried, et al.
Publicado: (2010)

Hyperidrosis: Excessive Sweating of the Hands
Publicado: (1883)

Milnacipran: recent findings in depression
por: Montgomery, Stuart, et al.
Publicado: (2010)

Antidepressant therapy with milnacipran and venlafaxine
por: Mansuy, Lucilla
Publicado: (2010)

Milnacipran for the management of fibromyalgia syndrome
por: Ormseth, Michelle J, et al.
Publicado: (2010)

Why does milnacipran produce so few discontinuation syndromes following abrupt withdrawal?
por: Okada, Fumihiko
Publicado: (2007)

A Painless Nodule with Excessive Sweating
por: Sharath Kumar, BC, et al.
Publicado: (2009)

The Use of Camphoric Acid in Excessive Sweating
por: Stockman, Ralph
Publicado: (1897)

Effect of milnacipran on body weight in patients with fibromyalgia
por: Arnold, Lesley M, et al.
Publicado: (2012)

Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
por: Hofmann, Peter
Publicado: (2010)

Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data
por: Lamy, Pierre-Jean, et al.
Publicado: (2020)

Human urinary cells for functional wound healing with sweat gland restoration
por: Ji, Shuai-Fei, et al.
Publicado: (2023)

Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Kranzler, Jay D, et al.
Publicado: (2010)

Evaluation of the Neurological Safety of Epidural Milnacipran in Rats
por: Lim, Seung Mo, et al.
Publicado: (2012)

Usefulness of milnacipran in treating phantom limb pain
por: Nagoshi, Yasuhide, et al.
Publicado: (2012)

Inadvertent dural puncture: Is excess flexion of spine a possible cause?
por: Kumar, Amarjeet, et al.
Publicado: (2020)

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
por: Avedisova, Alla, et al.
Publicado: (2009)

Effects of milnacipran on binge eating – a pilot study
por: Noma, Shun’ichi, et al.
Publicado: (2008)

Excess All-Cause Mortality During the COVID-19 Outbreak in Japan
por: Yorifuji, Takashi, et al.
Publicado: (2021)

Improvement of the noradrenergic symptom cluster following treatment with milnacipran
por: Kasper, Siegfried, et al.
Publicado: (2011)

Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy
por: Cho, Sun Jin, et al.
Publicado: (2023)

Marked effect of milnacipran combined with olanzapine for a delusional depressive patient
por: Sugawara, Yuka, et al.
Publicado: (2005)

Treatment of phantom bite syndrome with milnacipran – a case series
por: Toyofuku, Akira, et al.
Publicado: (2006)

Neuroscience research fails to support claims that excessive pornography consumption causes brain damage
por: Reid, Rory C., et al.
Publicado: (2011)

Letter to the editor: COVID-19 and all-cause excess mortality in Iran in spring 2020
por: Tadbiri, Hooman, et al.
Publicado: (2020)

Were the English Sweating Sickness and the Picardy Sweat Caused by Hantaviruses?
por: Heyman, Paul, et al.
Publicado: (2014)

In situ forming injectable MSC-loaded GelMA hydrogels combined with PD for vascularized sweat gland regeneration
por: Jirigala, Enhe, et al.
Publicado: (2023)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima, Kunitoshi, et al.
Publicado: (2013)

Excessive anxiety in IBD patients is unnecessary for COVID-19
por: Wang, Hong-Gang, et al.
Publicado: (2020)

A case of sweat-gland carcinoma with neuroendocrine differentiation
por: Koizumi, Shigeru, et al.
Publicado: (2022)

Hyperprolactinemia: An often missed cause of male infertility
por: Singh, Pratibha, et al.
Publicado: (2011)

Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan
por: Higuchi, Teruhiko, et al.
Publicado: (2007)

Milnacipran Remediates Impulsive Deficits in Rats with Lesions of the Ventromedial Prefrontal Cortex
por: Tsutsui-Kimura, Iku, et al.
Publicado: (2015)

Prevalence of excessive daytime sleepiness among patients with atopic dermatitis
por: Halioua, Bruno, et al.
Publicado: (2023)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9mt586b42o2vfrmfmevseeffah